High-Throughput Toxoplasma IgG ELISA Kit for Large-Scale Screening

Toxoplasmosis, caused by the intracellular protozoan parasite Toxoplasma gondii, is one of the most widespread parasitic infections globally. While often asymptomatic in healthy individuals, it poses significant health risks to specific populations, including pregnant women and immunocompromised individuals, where it can lead to severe neurological and ocular diseases. Furthermore, Toxoplasma gondii infection can have devastating economic impacts on the livestock industry, particularly in sheep and goats, causing abortion and neonatal death. The ability to accurately and efficiently detect past exposure to the parasite is critical for epidemiological studies, public health initiatives, and animal disease control programs. The High-Throughput Toxoplasma IgG ELISA Kit is a powerful diagnostic tool designed specifically to meet this need.

Figure 1. Toxoplasma Gondii.

The Global Challenge of Toxoplasmosis

Toxoplasma gondii has a complex life cycle involving a definitive host, the feline, and a wide range of intermediate hosts, including humans, livestock, and other mammals. Humans and animals typically become infected by ingesting oocysts from contaminated soil, water, or food, or by consuming undercooked meat containing tissue cysts.

Figure 2. Toxoplasma infection.

Public Health Significance

In humans, the public health concern primarily revolves around congenital toxoplasmosis. If a woman acquires a primary infection during pregnancy, the parasite can be transmitted to the fetus, leading to severe outcomes such as:

Chorioretinitis: Inflammation of the retina and choroid, which can cause vision loss.
Hydrocephalus: An abnormal accumulation of cerebrospinal fluid in the brain.
Intracerebral calcifications: Hardened deposits in the brain.
Miscarriage or stillbirth: In severe cases.

For immunocompromised individuals, such as those with HIV/AIDS or organ transplant recipients, a latent infection can reactivate, leading to life-threatening toxoplasmic encephalitis.

Veterinary and Economic Impact

In the veterinary world, toxoplasmosis is a major cause of reproductive failure in livestock. In sheep, for example, Toxoplasma gondii is a leading infectious cause of abortion, stillbirth, and mummified fetuses. This leads to substantial financial losses for farmers due to reduced flock productivity. Screening for Toxoplasma antibodies is crucial for herd management, especially in breeding flocks, to identify animals at risk and implement control measures.

The Diagnostic Imperative: Why ELISA is the Preferred Method

Diagnosing Toxoplasma gondii infection relies on detecting either the parasite itself or the host's immune response to it. Direct detection methods are often time-consuming, expensive, and lack the sensitivity for large-scale screening. Serological tests, which detect antibodies produced by the host, are the most practical approach for determining exposure status.
Traditional serological tests, such as the Sabin-Feldman Dye Test, are highly accurate but use live parasites and are difficult to standardize. The Indirect Fluorescent Antibody Test (IFAT) is another option but is subjective and labor-intensive, making it unsuitable for high-volume testing.
The Enzyme-Linked Immunosorbent Assay (ELISA) has emerged as the gold standard for serological screening due to its numerous advantages. A specific Toxoplasma IgG ELISA kit is designed to detect Immunoglobulin G (IgG) antibodies, which indicate a past or chronic infection, as they are the predominant antibody class produced after the initial acute phase.

Technology Platform

Sample Type

Serum
Plasma
Cell Culture Supernatant
Specialty Samples*

Performance Metrics

LOD: pg-ng/mL• Intra-assay CV<10%
Inter-assay CV<12%• Correlation with serum ≥90%
Optimized sensitivity for in vitro samples
Matrix-dependent performance• CV<20% for complex matrices

Applications

Clinical diagnosis, immunity assessment, therapeutic monitoring
Dynamic monitoring, high-throughput screening
Bioprocessing, yield monitoring, research experiments
Alternative matrix research, specific scenario applications

Product Specifications and Performance

Performance Characteristics

The kit's performance is validated for large-scale applications:
Sensitivity: Detects IgG antibodies at concentrations as low as 0.5 IU/mL, ensuring detection of early seroconversion (typically 2–4 weeks post-infection).
Specificity: >99% specificity, with no cross-reactivity observed with antibodies against Trypanosoma, Leishmania, or herpesviruses.
Precision: Intra-assay CV<6%, inter-assay CV <8%, ensuring consistency across high-volume runs.
Linear Range: 1–200 IU/mL, covering the full spectrum of antibody titers in clinical and population samples.
Automation Compatibility: Reagents and protocols are validated for use with automated liquid handlers (e.g., Hamilton, Tecan) and plate washers, reducing human error.

Storage and Stability

Unopened kit: Store at 2–8°C for 18 months from manufacture.
Opened reagents: Diluted wash buffer and sample dilution buffer are stable for 30 days at 2–8°C. HRP conjugate and TMB substrate (protected from light) remain stable for 60 days post-opening.
Pre-coated plates: Seal unused wells in a desiccator pouch with silica gel; stable for 30 days at 2–8°C.

Applications

The kit is designed for large-scale screening across diverse settings:
Prenatal Care: Routine screening of pregnant women to identify primary infections, enabling timely intervention (e.g., spiramycin prophylaxis) to prevent fetal transmission.
Immunocompromised Populations: Monitoring IgG levels in HIV/AIDS patients, organ transplant recipients, or cancer patients on immunosuppressive therapy to assess infection risk.
Epidemiological Surveys: Assessing T. gondii seroprevalence in regional or national populations to guide public health policies (e.g., food safety campaigns).
Veterinary and Food Safety: Screening livestock (e.g., pigs, sheep) to reduce zoonotic transmission via undercooked meat.

Principle of the Assay

The kit uses an indirect ELISA principle optimized for high throughput. Its 96-well microplate is pre-coated with purified T. gondii antigens (e.g., tachyzoite surface and dense granule proteins), conserved across major strains.
Antigen-Antibody Binding: Diluted samples are added; T. gondii-specific IgG antibodies bind to immobilized antigens.
Detection Conjugate: After washing, HRP-conjugated anti-human IgG is added, binding to captured IgG.
Chromogenic Reaction: TMB substrate is added; HRP converts it to blue, which turns yellow with stop solution (sulfuric acid).
Quantification: Absorbance at 450 nm (reference 630 nm) is measured; intensity correlates with T. gondii-specific IgG levels.

High-Throughput Toxoplasma IgG ELISA Kit for Large-Scale Screenings

Parameter	Details
Product name	Toxoplasma IgG ELISA Kit
Sample	serum, plasma, urine, aqueous humor, culture supernatants, other sample matrices
Storage	Enzyme Immunoassay for the Detection of IgG antibodies to Toxoplasma.
Contents of Kit	1. Microtiter Wells 2. Enzyme Conjugate Reagent 3. Sample Diluent 4. Calibrator 1 5. Calibrator 2 6. Calibrator 3 7. Calibrator 4 8. Low Control 9. High Control 10. Wash Buffer Concentrate (20X) 11. TMB Reagent (One-Step) 12. Stop Solution: 1N HCl

Advantages

Accuracy and Reliability

The use of highly specific, purified antigens minimizes cross-reactivity with other parasites, ensuring a low rate of false positives. The objective, numerical output from the microplate reader eliminates user-to-user variability, leading to highly reproducible and reliable results.

Mass Screening Capability

The 96-well plate format is the foundation of high-throughput testing. It allows for the simultaneous processing of dozens of samples, significantly reducing the time and cost per test. This is essential for large-scale epidemiological studies, screening blood donations, or testing entire animal flocks.

Objectivity

The results are read objectively by a microplate reader, which measures the optical density (OD) of the color change in each well. This numerical result eliminates the subjective interpretation inherent in older methods that rely on visual observation, such as the MAT.

Conclusion

The high-throughput toxoplasma IgG ELISA kit represents a powerful and practical solution to the global challenge of toxoplasmosis. Its ability to provide accurate, reliable, and cost-effective screening on a large scale is transforming public health initiatives and veterinary disease control. By enabling rapid and efficient detection of past exposure to the parasite, this technology empowers healthcare professionals, researchers, and veterinarians to make informed decisions that protect vulnerable populations and safeguard the economic viability of the livestock industry. As the need for large-scale surveillance grows, this advanced diagnostic tool will continue to play a pivotal role in the global effort to mitigate the impact of Toxoplasma gondii.

Inquiry Basket

Loading ......

Inquiry